মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

meridian medical technologies, inc. - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - morphine sulfate 10 mg in 0.7 ml - morphine sulfate injection is indicated for the management of pain severe enough to require an opioid analgesic and for which alternative treatments are inadequate. limitations of use because of the risks of addiction, abuse, and misuse with opioids, even at recommended doses [see warnings and precautions (5.1)] , reserve morphine sulfate injection for use in patients for whom alternative treatment options (e.g., non-opioid analgesics or opioid combination products): - have not been tolerated, or are not expected to be tolerated, - have not provided adequate analgesia, or are not expected to provide adequate analgesia morphine sulfate injection is contraindicated in patients with: - significant respiratory depression [see warnings and precautions (5.2)] - acute or severe bronchial asthma in an unmonitored setting or in the absence of resuscitative equipment [see warnings and precautions (5.5)] - concurrent use of monoamine oxidase inhibitors (maois) or use of maois within the last 14 days [see warnings and pr

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

par pharmaceutical inc. - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - morphine sulfate 20 mg - morphine sulfate extended-release capsules, usp are an extended-release oral formulation of morphine sulfate indicated for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time (seeclinical pharmacology ). morphine sulfate extended-release capsules, usp are not indicated for pain in the immediate postoperative period (the first 12 to 24 hours following surgery), or if the pain is mild or not expected to persist for an extended period of time. morphine sulfate extended-release capsules, usp are only indicated for postoperative use if the patient is already receiving the drug prior to surgery or if the postoperative pain is expected to be moderate to severe and persist for an extended period of time. physicians should individualize treatment, moving from parenteral to oral analgesics as appropriate. (see american pain society guidelines.) morphine sulfate extended-release capsules are contraindicated in patients with a known hyper

মার্কিন যুক্তরাষ্ট্র - ইংরেজি - NLM (National Library of Medicine)

stat rx usa llc - morphine sulfate (unii: x3p646a2j0) (morphine - unii:76i7g6d29c) - morphine sulfate 15 mg - morphine sulfate extended-release tablets are an extended-release oral formulation of morphine sulfate indicated for the management of moderate to severe pain when a continuous, around-the-clock opioid analgesic is needed for an extended period of time. morphine sulfate extended-release tablets are not intended for use as a prn analgesic. the morphine sulfate extended-release tablets 100 mg and 200 mg strengths are high dose, extended-release, oral morphine formulations indicated for the relief of pain in opioid-tolerant patients only. morphine sulfate extended-release tablets are not indicated for pain in the immediate postoperative period (the first 12 to 24 hours following surgery) for patients not previously taking the drug, because its safety in this setting has not been established. morphine sulfate extended-release tablets are not indicated for pain in the postoperative period if the pain is mild, or not expected to persist for an extended period of time. morphine sulfate extended-release tablets are o

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

medsurge pharma limited - morphine sulfate pentahydrate 10 mg/ml;   - solution for injection - 10 mg/ml - active: morphine sulfate pentahydrate 10 mg/ml   excipient: hydrochloric acid nitrogen sodium chloride water for injection - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

medsurge pharma limited - morphine sulfate pentahydrate 15 mg/ml;   - solution for injection - 15 mg/ml - active: morphine sulfate pentahydrate 15 mg/ml   excipient: hydrochloric acid nitrogen sodium chloride water for injection - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

medsurge pharma limited - morphine sulfate pentahydrate 2 mg/ml;   - solution for injection - 2 mg/ml - active: morphine sulfate pentahydrate 2 mg/ml   excipient: hydrochloric acid nitrogen sodium chloride water for injection - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

medsurge pharma limited - morphine sulfate pentahydrate 30 mg/ml;   - solution for injection - 30 mg/ml - active: morphine sulfate pentahydrate 30 mg/ml   excipient: hydrochloric acid nitrogen sodium chloride water for injection - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

medsurge pharma limited - morphine sulfate pentahydrate 5 mg/ml;   - solution for injection - 5 mg/ml - active: morphine sulfate pentahydrate 5 mg/ml   excipient: hydrochloric acid nitrogen sodium chloride water for injection - the short-term management of severe pain for which other treatment options have failed, are contraindicated, not tolerated or are otherwise inappropriate to provide sufficient management of pain.

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - morphine sulfate pentahydrate 15 mg/ml - solution for injection - 15 mg/ml - active: morphine sulfate pentahydrate 15 mg/ml excipient: hydrochloric acid sodium chloride water for injection - latest regulatory activity

নিউ জিলণ্ড - ইংরেজি - Medsafe (Medicines Safety Authority)

pfizer new zealand limited - morphine sulfate pentahydrate 10 mg/ml - solution for injection - 10 mg/ml - active: morphine sulfate pentahydrate 10 mg/ml excipient: hydrochloric acid sodium chloride water for injection - latest regulatory activity